Lilly invests $4.5B in Indiana manufacturing, opens doors of 1st genetic medicine site

Eli Lilly’s latest manufacturing expansion will support production of obesity blockbusters and next-gen assets, while the new Lilly Lebanon Advanced Therapies site will take experimental genetic medicines from research to commercialization.